Skip to content The lifesciences industry is being reshaped by scientific breakthroughs, technological disruption, and the rise of patients as empowered consumers.
From early drug discovery through to prelaunch strategy and postlaunch/maturity STRAT7 helps you see what’s coming and act before markets shift. We bring foresight, strategic clarity, and bold thinking that turn complexity into competitive advantage.
Whether it’s shaping investment decisions for early-stage assets, building portfolio strategies that anticipate regulatory and competitive shifts, crafting launch and customer engagement plans that resonates with scientists, clinicians and patients for years not months, or driving therapeutic franchise growth before opportunities become competitive battlegrounds – we help you move forward with conviction.
A global tech-enabled strategy, insights and analytics agency
01
Our integrated ecosystem
Our integrated ecosystem brings together senior experts in consulting, insight, and foresight — complemented by perspectives from other sectors. This blend gives you a richer, more rounded understanding of your challenges and ensures your strategy is shaped by both deep industry knowledge and broader commercial thinking.
02
Trusted advisor relationships
Our teams are led by trusted advisors with over 20 years of experience and deep industry knowledge who understand you and your business. We build relationships where your teams feel challenged, supported, and inspired to embrace the outcomes and make them happen.
03
Innovative methodologies
We utilise both proven methodologies and sophisticated new approaches – from hybrid segmentation that drives deployment to AI tools that stimulate creativity and bring your customer into the decision making. The right methodology for the right challenge, delivered by specialists who can execute brilliantly.
Trusted by
Capturing strategic insights
With 20 years of deep sector knowledge, we understand the distinct challenges and opportunities each sector faces – whether you’re an established pharmaceutical company, a fast-moving biotech, or a medtech innovator. Our experience spans the full spectrum of healthcare businesses.
We work closely with established pharmaceutical companies to assess opportunities, define markets, shape value propositions, and plan launches, partnerships, funding, and lifecycle strategies to drive strong commercial performance in competitive, fast-moving environments.
We help medical devices, equipment and digital health businesses understand evolving customer expectations, navigate regulatory and reimbursement challenges, and overcome adoption barriers – turning technical innovation into commercial success.
Our Biotechnology division supports companies supplying tools and services for therapeutic discovery, development, and manufacturing – from lab purification to chromatography and large-scale bioreactors – helping clients stay competitive in a fast-evolving bioprocessing landscape.
We combine proven methodologies with innovative approaches to deliver the perspectives that shape winning strategies, from segmentation that drives decisions to cultural insights that spot shifts before competitors.
With over 2,000 segmentations delivered across industries, we understand how to make segmentation drive real business impact – not just describe your market, but shape strategic decisions. We set clear ambitions, choose the right segmentation approach for your needs, and build deployment plans that ensure insights translate into action. From hybrid segmentation that integrates with CRM systems to strategic frameworks that guide portfolio decisions, we make segmentation work in practice.
Healthcare customers have the same expectations as they do in banking, retail, or consumer goods – yet pharma has historically been product-first, not customer-first. We help you spot cultural shifts before competitors do and adapt your strategy to stay relevant. From ethnographic research that captures authentic patient realities to semiotic analysis that forecasts future scenarios, we give you a culturally-charged advantage that shapes positioning, messaging, and innovation.
Insight communities give you direct access to clinicians and patients for agile, real-time decision-making – ensuring their voices shape your strategy, not just validate it. Whether you need a long-term resource across multiple projects or a focused community for a single purpose like pre-launch strategy, communities offer a cost-effective way to stay connected to the stakeholders who matter most.
Our AI platform, Nucleus, is purpose-built for insight professionals – not generic AI adapted for research. With over 20 years of automated insight solutions, we understand how to use AI to accelerate insights without compromising quality or security. Nucleus powers all our healthcare capabilities: rapid synthesis of complex datasets through STRAT7 GPT, qualitative research with WhyCatcher, segment chatbots that bring customer voices into decision-making, and digital twins for strategic planning. We match the right tools to the right challenge, with human expertise at every critical decision point and enterprise-grade data security as standard.
If you’d like to find out how we can help, fill in the form and someone from our healthcare team will be in touch shortly.
BannerText_Seraphinite Accelerator
